switch semaglutide to tirzepatide Switching Conversion from tirzepatide to semaglutide:
Description
It is available under two brand names and indications: Zepbound Weight loss for people with obesity (BMI of 30 or higher) or Weight loss for people with overweight (BMI of 27 or higher) who have a weight-related health condition like high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease Mounjaro Blood sugar control for people with type 2 diabetes Tirzepatide is a dual-agonist GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) medication
Quick Answer: A bad taste in the mouth with GLP-1 medications is an uncommon side effect, typically related to delayed gastric emptying and gastrointestinal effects, and often improves within 4 to 8 weeks
Really good
Some of these Mounjaro patients even experienced severe and life-threatening gastrointestinal complications that required surgery and other kinds of emergency treatment
